Accolade, Inc. (NASDAQ:ACCD) Q1 2024 Earnings Call Transcript June 29, 2023 Accolade, Inc. beats earnings expectations. Reported EPS is $-0.52, expectations were $-0.62. Operator: Good day, and thank you for standing by, and welcome to Accolade First Quarter ’24 Earnings Results Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I […]
Accolade and Equip offer employers purpose-built integrations to address barriers to eating disorder treatment.
SEATTLE, June 7, 2023 /PRNewswire/ Accolade, Inc. , the company that provides. | June 7, 2023
Operator: Good day and thank you for standing by and welcome to the Accolade Fourth Quarter 2023 Earnings Results Conference Call. At this time all participants are in a listen-only mode.
/PRNewswire/ Accolade, Inc. (Nasdaq: ACCD), the company that provides millions of people and their families with Personalized Healthcare, has partnered with.
Operator: Thank you for standing by and welcome to the Accolade Third Quarter Conference Call. At this time all participants are in a listen-only mode.